Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
On this page:OverviewPublicationsKey papers
ScholarIQanswers from OpenAlex & ORCID

Ahsan Alam

ResearcherPublications, citations & collaboration network

Ahsan Alam is a researcher indexed in ScholarIQ from OpenAlex & ORCID. ScholarIQ records 3 works, 1 citations, an h-index of 1 and an i10-index of 0.

3
Works
1
Citations
1
h-index
0
i10-index

How has Ahsan Alam's publication output changed over time?

ScholarIQpublication output · 2025–2026

Output grew100% over the shown period — from 1 works in 2025 to 2 in 2026.

1
2
20252026

What are the most-cited papers on Ahsan Alam?

ScholarIQmost cited works
Eight Years of Canadian Real-World Assessment of Tolvaptan in Patients With Autosomal Dominant Polycystic Kidney Disease: The C-MAJOR Registry
Philip McFarlane, Daniel G. Bichet, Ahsan Alam, Suzy Bubolic, Annick Laplante
Canadian Journal of Kidney Health and Disease. 20261 CitationsOPEN ACCESS
Nephrectomy in autosomal dominant polycystic kidney disease: a consensus statement of the ERA Genes & Kidney Working Group
Paul Geertsema, Ron T Gansevoort, Mustafa Arici, Giovambattista Capasso, Emilie CORNEC-LE GALL, Monica Furlano, Daniel G. Fuster, Flavia Galletti, Victoria Gómez Dos Santos, Maria Vanessa Perez Gomez, Dimitrios Goumenos, Jan Halbritter, Eva Jambon, Uwe Korst, Anna M. Leliveld, Mireia Musquera, Arnaldo Figueiredo, Tom Nijenhuis, Jonathon Olsburgh, Robert Pol, John A Sayer, Dirk L. Stippel, Roser Torra, Roman-Ulrich Müller, Niek F. Casteleijn, members of the study group, Ahsan Alam, Bert Bammens, Malte P. Bartram, Henrik Birn, et al., Olivier Devuyst
20250 CitationsOPEN ACCESS
WCN26-4375 EIGHT YEARS OF CANADIAN REAL-WORLD ASSESSMENT OF TOLVAPTAN IN ADPKD: PATIENT REPORTED OUTCOMES FROM THE C-MAJOR STUDY
Phil McFarlane, Daniel G. Bichet, Ahsan Alam, Dorothee Oberdhan, Suzy Bubolic, Annick Laplante
Kidney International Reports. 20260 CitationsOPEN ACCESS

Related on ScholarIQ

McGill University Health Centre
Institution
Eight Years of Canadian Real-World Assessment of Tolvaptan in Patients With Autosomal Dominant Polycystic Kidney Disease: The C-MAJOR Registry
Paper
Nephrectomy in autosomal dominant polycystic kidney disease: a consensus statement of the ERA Genes & Kidney Working Group
Paper
WCN26-4375 EIGHT YEARS OF CANADIAN REAL-WORLD ASSESSMENT OF TOLVAPTAN IN ADPKD: PATIENT REPORTED OUTCOMES FROM THE C-MAJOR STUDY
Paper
Genetic and Kidney Cyst Diseases
Topic
Atrial Fibrillation Management and Outcomes
Topic
470M+ articles · free account